Soluble α-synuclein is a novel modulator of Alzheimer's disease pathophysiology.

Volume: 32, Issue: 30, Pages: 10253 - 10266
Published: Jul 25, 2012
Abstract
Recent evidence has emphasized soluble species of amyloid-β (Aβ) and tau as pathogenic effectors in Alzheimer's disease (AD). Despite the fact that Aβ, tau, and α-synuclein (αSyn) can promote each other's aggregation, the potential contribution of soluble αSyn to AD pathogenesis is unknown. Here, we found an approximate twofold increase over controls in soluble αSyn levels in AD brains in the absence of Lewy body cytopathology. Importantly,...
Paper Details
Title
Soluble α-synuclein is a novel modulator of Alzheimer's disease pathophysiology.
Published Date
Jul 25, 2012
Volume
32
Issue
30
Pages
10253 - 10266
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.